- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
OFI Invest Asset Management Acquires $655,000 Stake in Quest Diagnostics
The investment firm adds new position in medical research company's stock
Apr. 10, 2026 at 10:26am
Got story updates? Submit your updates here. ›
A close-up view of the complex machinery and technology that powers the medical diagnostics industry, highlighting the critical role of advanced testing in modern healthcare.Aurora TodayOFI Invest Asset Management acquired a new position in shares of Quest Diagnostics Incorporated (NYSE:DGX) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 3,777 shares of the medical research company's stock, valued at approximately $655,000.
Why it matters
Quest Diagnostics is a leading provider of diagnostic information services that support clinical decision-making for patients, physicians and healthcare organizations. This investment by OFI Invest Asset Management signals confidence in the company's growth potential within the medical research and diagnostics industry.
The details
A number of other institutional investors have also recently bought and sold shares of Quest Diagnostics. Perigon Wealth Management LLC, Independent Advisor Alliance, True North Advisors LLC, and Ossiam all increased their positions in the company during the third quarter of 2022.
- OFI Invest Asset Management acquired the new position in the fourth quarter of 2022.
- Quest Diagnostics declared a quarterly dividend that will be paid on April 20, 2026.
The players
Quest Diagnostics Incorporated
A leading provider of diagnostic information services that supports clinical decision-making for patients, physicians and healthcare organizations.
OFI Invest Asset Management
An investment firm that acquired a new position in shares of Quest Diagnostics in the fourth quarter of 2022.
What’s next
Investors will be watching to see if Quest Diagnostics continues to make strategic investments and acquisitions to expand its diagnostic services and capabilities.
The takeaway
This investment by OFI Invest Asset Management underscores the growth potential of the medical diagnostics industry, as healthcare providers and patients increasingly rely on advanced testing and analysis to inform clinical decisions.
